logo

A COVID-19 Pneumonia Responded to Photobiomodulation Therapy

PDF Publication Title:

A COVID-19 Pneumonia Responded to Photobiomodulation Therapy ( a-covid-19-pneumonia-responded-photobiomodulation-therapy )

Previous Page View | Next Page View | Return to Search List

Text from PDF Page: 007

Sigman S.A. et al.: A 57-year-old African American man with severe COVID-19 pneumonia... © Am J Case Rep, 2020; 21: e926779 References: 1. Liang T: Handbook of COVID-19 prevention and treatment. Zhejiang University School of Medicine, March 2020 2. Huang C, Wang Y, Li X et al: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;]. Lancet, 2020; 395(10223): 497–506 3. Anders JJ, Lanzafame RJ, Arany PR: Low-level light/laser therapy versus pho- tobiomodulation therapy. Photomed Laser Surg, 2015; 33(4): 183–84 4. Cotler HB, Chow RT, Hamblin MR, Carroll J: The use of low-level laser ther- apy (LLLT) for musculoskeletal pain. MOJ Orthop Rheumatol, 2015; 2(5): 00068 5. Hamblin MR: Mechanisms and applications of the anti-inflammatory ef- fects of photobiomodulation. AIMS Biophys, 2017; 4(3): 337–61 6. Amirov NB [Parameters of membrane permeability, microcirculation, ex- ternal respiration, and trace element levels in the drug-laser treatment of pneumonia]. Ter Arkh, 2002; 74(3): 40–43 [in Russsian] 7. Derbenev VA, Mikhailov VA, Denisov IN: Use of low-level laser therapy (LLLT) in the treatment of some pulmonary diseases: Ten-year experience. Proceedings of the SPIE, Volume 4166; 1999 Oct 28–31; Florence, Italy. SPIE digital library 2000; 323–25 8. Ostronosova NS: [Outpatient use of laser therapy in bronchial asthma.] Ter Arkh, 2006; 78(3): 41–44 [in Russsian] 9. Mehani SHM: Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease. J Phys Ther Sci, 2017; 29(9): 1527–33 10. Miranda EF, de Oliveira LV, Antonialli FC et al: Phototherapy with combi- nation of super-pulsed laser and light-emitting diodes is beneficial in im- provement of muscular performance (strength and muscular endurance), dyspnea, and fatigue sensation in patients with chronic obstructive pul- monary disease. Lasers Med Sci, 2015; 30(1): 437–43 11. Enwemeka CS, Bumah VV, Masson-Meyers DS: Light as a potential treat- ment for pandemic coronavirus infections: A perspective. J Photochem Photobiol B, 2020; 207: 111891 12. Fekrazad R: Photobiomodulation and antiviral photodynamic therapy as a possible novel approach in COVID-19 management. Photobiomodul Photomed Laser Surg, 2020; 38(5): 255–57 13. Mokmeli S, Vetrici M: Low-level laser therapy as a modality to attenuate cytokine storm at multiple levels, enhance recovery, and reduce the use of ventilators in COVID-19. Can J Respir Ther, 2020; 56: 1–7 14. Aimbire F, Lopes-Martins RA, Albertini R et al: Effect of low-level laser therapy on hemorrhagic lesions induced by immune complex in rat lungs. Photomed Laser Surg, 2007; 25(2): 112–17 15. de Brito AA, da Silveira EC, Rigonato-Oliveira NC et al: Low-level laser ther- apy attenuates lung inflammation and airway remodeling in a murine mod- el of idiopathic pulmonary fibrosis: Relevance to cytokines secretion from lung structural cells. J Photochem Photobiol B, 2020; 203: 111731 16. Cury V, de Lima TM, Prado CM et al: Low-level laser therapy reduces acute lung inflammation without impairing lung function. J Biophotonics, 2016; 9(11–12): 1199–207 17. da Cunha Moraes G, Vitoretti LB, de Brito AA et al: Low-level laser therapy reduces lung inflammation in an experimental model of chronic obstructive pulmonary disease involving P2X7 receptor. Oxid Med Cell Longev, 2018; 2018: 6798238 18. Miranda da Silva C, Peres Leal M, Brochetti RA et al: Low-level laser ther- apy reduces the development of lung inflammation induced by formalde- hyde exposure. PLoS One, 2015; 10(11): e0142816 19. WALT: Dosage recommendations. Recommended treatment doses for low- level laser therapy. Available at URL: https://waltza.co.za/documentation- links/recommendations/dosage-recommendations/; https://waltza.co.za/ wp-content/uploads/2012/08/Dose_table_904nm_for_Low_Level_Laser_ Therapy_WALT-2010.pdf 20. Tunér J, Hode L: Laser therapy, clinical practice and scientific background. Grängesberg, Sweden: Prima Books AB; 2002 21. Hudson DE, Hudson DO, Wininger JM, Richardson BD: Penetration of laser light at 808and 980nm in bovine tissue samples. Photomed Laser Surg, 2013; 31(4): 163–68 22. Arza RA: Upper and lower respiratory conditions. In: Riegel RJ, Godbold JC (eds.), Laser therapy in veterinary medicine. Hoboken: John Wiley & Sons, Inc., 2017; 150–60 23. Vatankhah Z, Mokmeli S, Boshbishe S: Evaluation of the effect of low-lev- el laser therapy (LLLT) in the treatment of asthma, added to convention- al drug therapy (crossover, case control clinical trial). Photodiagnosis and Photodynamic Therapy, 2008; 5(Suppl. 1): S22 24. Community-Acquired Pneumonia Severity Index (PSI) for Adults; Community- Acquired Pneumonia Severity Index (PSI) for Adults Calculator. https://www. merckmanuals.com/medical-calculators/CommunityAcqPneumonia.htm 25. Charles PG, Wolfe R, Whitby M et al: SMART-COP: A tool for predicting the need for intensive respiratory or vasopressor support in community-ac- quired pneumonia. Clin Infect Dis, 2008; 47(3): 375–84 26. Duca A, Piva S, Focà E et al: Calculated decisions: Brescia-COVID Respiratory Severity Scale (BCRSS)/algorithm. Emerg Med Pract, 2020; 22(5 Suppl.): CD1–2 27. El Moussaoui R, Opmeer BC, Bossuyt PM et al: Development and valida- tion of a short questionnaire in community acquired pneumonia. Thorax, 2004; 59(7): 591–95 28. Zimatore C, Pisani L, Lippolis V et al: The radiographic assessment of lung edema (RALE) score has excellent diagnostic accuracy for ARDS. Eur Respir J, 2019; 54(Suppl. 63): OA3299 29. Wong HYF, Lam HYS, Fong AH et al: Frequency and distribution of chest radiographic findings in patients positive for COVID-19. Radiology, 2020; 296(2): E72–78 30. Phua J, Weng L, Ling L et al: Intensive care management of coronavirus dis- ease 2019 (COVID-19): challenges and recommendations [published cor- rection appears in Lancet Respir Med. 2020 May;8(5): e42]. Lancet Respir Med, 2020; 8(5): 506–17 31. Micheli L, Cialdai F, Pacini A et al: Effect of NIR laser therapy by MLS-MiS source against neuropathic pain in rats: In vivo and ex vivo analysis. Sci Rep, 2019; 9(1): 9297 32. Micheli L, Di Cesare Mannelli L, Lucarini E et al: Photobiomodulation ther- apy by NIR laser in persistent pain: An analytical study in the rat. Lasers Med Sci, 2017; 32(8): 1835–46 33. Monici M, Cialdai F, Ranaldi F et al: Effect of IR laser on myoblasts: A pro- teomic study. Mol Biosyst, 2013; 9(6): 1147–61 34. Henderson WR, Griesdale DE, Dominelli P, Ronco JJ: Does prone position- ing improve oxygenation and reduce mortality in patients with acute re- spiratory distress syndrome? Can Respir J, 2014; 21(4): 213–15 35. Guérin C, Reignier J, Richard JC et al: Prone positioning in severe acute re- spiratory distress syndrome. N Engl J Med, 2013; 368(23): 2159–68 This work is licensed under Creative Common Attribution- NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) 7 Indexed in: [PMC] [PubMed] [Emerging Sources Citation Index (ESCI)] [Web of Science by Clarivate] APPROVED GALLEY PROOF

PDF Image | A COVID-19 Pneumonia Responded to Photobiomodulation Therapy

a-covid-19-pneumonia-responded-photobiomodulation-therapy-007

PDF Search Title:

A COVID-19 Pneumonia Responded to Photobiomodulation Therapy

Original File Name Searched:

laser-therapy-severe-COVID-19-case.pdf

DIY PDF Search: Google It | Yahoo | Bing

Cruise Ship Reviews | Luxury Resort | Jet | Yacht | and Travel Tech More Info

Cruising Review Topics and Articles More Info

Software based on Filemaker for the travel industry More Info

The Burgenstock Resort: Reviews on CruisingReview website... More Info

Resort Reviews: World Class resorts... More Info

The Riffelalp Resort: Reviews on CruisingReview website... More Info

CONTACT TEL: 608-238-6001 Email: greg@cruisingreview.com | RSS | AMP